These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 12161021

  • 1. Transient anti-CD154-mediated immunotherapy of ongoing relapsing experimental autoimmune encephalomyelitis induces long-term inhibition of disease relapses.
    Howard LM, Dal Canto MC, Miller SD.
    J Neuroimmunol; 2002 Aug; 129(1-2):58-65. PubMed ID: 12161021
    [Abstract] [Full Text] [Related]

  • 2. Autoimmune intervention by CD154 blockade prevents T cell retention and effector function in the target organ.
    Howard LM, Miller SD.
    J Immunol; 2001 Feb 01; 166(3):1547-53. PubMed ID: 11160195
    [Abstract] [Full Text] [Related]

  • 3. Mechanisms of immunotherapeutic intervention by anti-CD40L (CD154) antibody in an animal model of multiple sclerosis.
    Howard LM, Miga AJ, Vanderlugt CL, Dal Canto MC, Laman JD, Noelle RJ, Miller SD.
    J Clin Invest; 1999 Jan 01; 103(2):281-90. PubMed ID: 9916140
    [Abstract] [Full Text] [Related]

  • 4. Normal Th1 development following long-term therapeutic blockade of CD154-CD40 in experimental autoimmune encephalomyelitis.
    Howard LM, Ostrovidov S, Smith CE, Dal Canto MC, Miller SD.
    J Clin Invest; 2002 Jan 01; 109(2):233-41. PubMed ID: 11805135
    [Abstract] [Full Text] [Related]

  • 5. FcR interactions do not play a major role in inhibition of experimental autoimmune encephalomyelitis by anti-CD154 monoclonal antibodies.
    Nagelkerken L, Haspels I, van Rijs W, Blauw B, Ferrant JL, Hess DM, Garber EA, Taylor FR, Burkly LC.
    J Immunol; 2004 Jul 15; 173(2):993-9. PubMed ID: 15240687
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of treatment with a small-molecule VLA-4 antagonist before and after onset of relapsing EAE.
    Theien BE, Vanderlugt CL, Nickerson-Nutter C, Cornebise M, Scott DM, Perper SJ, Whalley ET, Miller SD.
    Blood; 2003 Dec 15; 102(13):4464-71. PubMed ID: 12933585
    [Abstract] [Full Text] [Related]

  • 7. Immunotherapy targeting the CD40/CD154 costimulatory pathway for treatment of autoimmune disease.
    Howard LM, Miller SD.
    Autoimmunity; 2004 Aug 15; 37(5):411-8. PubMed ID: 15621565
    [Abstract] [Full Text] [Related]

  • 8. Discordant effects of anti-VLA-4 treatment before and after onset of relapsing experimental autoimmune encephalomyelitis.
    Theien BE, Vanderlugt CL, Eagar TN, Nickerson-Nutter C, Nazareno R, Kuchroo VK, Miller SD.
    J Clin Invest; 2001 Apr 15; 107(8):995-1006. PubMed ID: 11306603
    [Abstract] [Full Text] [Related]

  • 9. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A, Adlard K, Zamora A, Silverman M, Vandenbark AA, Offner H.
    J Neurosci Res; 2001 Sep 15; 65(6):529-42. PubMed ID: 11550221
    [Abstract] [Full Text] [Related]

  • 10. Surgical excision of CNS-draining lymph nodes reduces relapse severity in chronic-relapsing experimental autoimmune encephalomyelitis.
    van Zwam M, Huizinga R, Heijmans N, van Meurs M, Wierenga-Wolf AF, Melief MJ, Hintzen RQ, 't Hart BA, Amor S, Boven LA, Laman JD.
    J Pathol; 2009 Mar 15; 217(4):543-51. PubMed ID: 19023878
    [Abstract] [Full Text] [Related]

  • 11. The type IV phosphodiesterase specific inhibitor mesopram inhibits experimental autoimmune encephalomyelitis in rodents.
    Dinter H, Tse J, Halks-Miller M, Asarnow D, Onuffer J, Faulds D, Mitrovic B, Kirsch G, Laurent H, Esperling P, Seidelmann D, Ottow E, Schneider H, Tuohy VK, Wachtel H, Perez HD.
    J Neuroimmunol; 2000 Aug 01; 108(1-2):136-46. PubMed ID: 10900347
    [Abstract] [Full Text] [Related]

  • 12. Relapsing and remitting experimental allergic encephalomyelitis: a focused response to the encephalitogenic peptide rather than epitope spread.
    Takács K, Chandler P, Altmann DM.
    Eur J Immunol; 1997 Nov 01; 27(11):2927-34. PubMed ID: 9394820
    [Abstract] [Full Text] [Related]

  • 13. Pathologic role and temporal appearance of newly emerging autoepitopes in relapsing experimental autoimmune encephalomyelitis.
    Vanderlugt CL, Neville KL, Nikcevich KM, Eagar TN, Bluestone JA, Miller SD.
    J Immunol; 2000 Jan 15; 164(2):670-8. PubMed ID: 10623809
    [Abstract] [Full Text] [Related]

  • 14. Prevention and treatment of relapsing autoimmune encephalomyelitis with myelin peptide-coupled splenocytes.
    Vandenbark AA, Vainiene M, Ariail K, Miller SD, Offner H.
    J Neurosci Res; 1996 Aug 15; 45(4):430-8. PubMed ID: 8872903
    [Abstract] [Full Text] [Related]

  • 15. The CD154-CD40 T-cell co-stimulation pathway in liver ischemia and reperfusion inflammatory responses.
    Ke B, Shen XD, Gao F, Tsuchihashi S, Farmer DG, Briscoe D, Busuttil RW, Kupiec-Weglinski JW.
    Transplantation; 2005 May 15; 79(9):1078-83. PubMed ID: 15880047
    [Abstract] [Full Text] [Related]

  • 16. CD40L blockade prevents autoimmune encephalomyelitis and hampers TH1 but not TH2 pathway of T cell differentiation.
    Samoilova EB, Horton JL, Zhang H, Chen Y.
    J Mol Med (Berl); 1997 Aug 15; 75(8):603-8. PubMed ID: 9297628
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Bifidobacterium animalis in combination with human origin of Lactobacillus plantarum ameliorate neuroinflammation in experimental model of multiple sclerosis by altering CD4+ T cell subset balance.
    Salehipour Z, Haghmorad D, Sankian M, Rastin M, Nosratabadi R, Soltan Dallal MM, Tabasi N, Khazaee M, Nasiraii LR, Mahmoudi M.
    Biomed Pharmacother; 2017 Nov 15; 95():1535-1548. PubMed ID: 28946394
    [Abstract] [Full Text] [Related]

  • 20. Dependency of direct pathway CD4+ T cells on CD40-CD154 costimulation is determined by nature and microenvironment of primary contact with alloantigen.
    van Maurik A, Fazekas de St Groth B, Wood KJ, Jones ND.
    J Immunol; 2004 Feb 15; 172(4):2163-70. PubMed ID: 14764682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.